MedicationUse2-v1.0(2017EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
Geen bewerkingssamenvatting
Geen bewerkingssamenvatting
Regel 3: Regel 3:
Version: '''1.0''' <br>
Version: '''1.0''' <br>
HCIM Status:Final<br>
HCIM Status:Final<br>
Publication: '''2017''' <br>
Release: '''2017''' <br>
Release status: Prepublished<br>
Release status: Prepublished<br>
Publication date: 04-09-2017
Release date: 04-09-2017
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
Regel 74: Regel 74:
==Information Model==
==Information Model==
<BR>
<BR>
[[Bestand: MedicationUse2-v1.0Model(EN).png | center]]
<imagemap> Bestand:MedicationUse2-v1.0Model(EN).png | center  
rect 179 91 291 155 [[HealthProfessional-v3.1(2017EN)]]
rect 496 480 731 540 [[#ReasonForChangeOrDiscontinuationOfUseCodList]]
rect 762 480 962 540 [[#MedicationUseStopTypeCodeList]]
rect 745 373 887 443 [[#13447]]
rect 629 91 741 161 [[#13449]]
rect 479 91 591 155 [[InstructionsForUse-v1.0(2017EN)]]
rect 775 236 886 300 [[#13450]]
rect 329 91 441 155 [[Product-v1.0(2017EN)]]
rect 774 93 886 163 [[#13455]]
rect 170 229 312 299 [[#13448]]
rect 513 374 684 444 [[#13445]]
rect 333 374 475 444 [[TimeInterval-v1.0(2017EN)]]
rect 166 373 308 443 [[#13451]]
rect 488 229 599 299 [[#13453]]
desc none
</imagemap>
<BR>
<BR>
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
Regel 80: Regel 96:
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px]]
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:9.11.21338
||NL-CM:9.11.21338
|colspan ="6" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px]]MedicationUse</span>
|colspan ="6" style ="padding-left: 0px"|<span Id=13453 Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px | link=]]MedicationUse</span>
|
|
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
Regel 88: Regel 104:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.23290
||NL-CM:9.11.23290
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Voorschrijver::Zorgverlener">[[Bestand: arrowright.png | 10px]]Prescriber::HealthProfessional</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13452 Title="NL: Voorschrijver::Zorgverlener">[[Bestand: arrowright.png | 10px | link=]]Prescriber::HealthProfessional</span>
|0..1
|0..1
|The health professional that entered the medication agreement with the patient.
|The health professional that entered the medication agreement with the patient.
Regel 98: Regel 114:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[HealthProfessional-v3.1(2017EN) |HealthProfessional]]
|[[Bestand: block.png | link=HealthProfessional-v3.1(2017EN)]]||[[HealthProfessional-v3.1(2017EN) |HealthProfessional]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.21339
||NL-CM:9.11.21339
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksproduct::Product">[[Bestand: arrowright.png | 10px]]ProductUsed::Product</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13454 Title="NL: Gebruiksproduct::Product">[[Bestand: arrowright.png | 10px | link=]]ProductUsed::Product</span>
|1
|1
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.  
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.  
Regel 113: Regel 129:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[Product-v1.0(2017EN) |Product]]
|[[Bestand: block.png | link=Product-v1.0(2017EN)]]||[[Product-v1.0(2017EN) |Product]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.22504
||NL-CM:9.11.22504
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px]]InstructionsForUse</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13457 Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px | link=]]InstructionsForUse</span>
|0..1
|0..1
|Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.
|Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.
Regel 126: Regel 142:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]]
|[[Bestand: block.png | link=InstructionsForUse-v1.0(2017EN)]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px]]
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:9.11.22398
||NL-CM:9.11.22398
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikDatumTijd">[[Bestand: arrowright.png | 10px]]MedicationUseDateTime</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13451 Title="NL: MedicatieGebruikDatumTijd">[[Bestand: arrowright.png | 10px | link=]]MedicationUseDateTime</span>
|1
|1
|Date on which this use is entered.
|Date on which this use is entered.
Regel 138: Regel 154:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.22663
||NL-CM:9.11.22663
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px]]PeriodOfUse</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13456 Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px | link=]]PeriodOfUse</span>
|0..1
|0..1
|<b>Start date</b>: This is the time at which the agreement was to take effect (or took effect or will take effect).  
|<b>Start date</b>: This is the time at which the agreement was to take effect (or took effect or will take effect).  
Regel 150: Regel 166:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[TimeInterval-v1.0(2017EN) |TimeInterval]]
|[[Bestand: block.png | link=TimeInterval-v1.0(2017EN)]]||[[TimeInterval-v1.0(2017EN) |TimeInterval]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px]]
|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
||NL-CM:9.11.22492
||NL-CM:9.11.22492
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: VolgensAfspraakIndicator">[[Bestand: arrowright.png | 10px]]AsAgreedIndicator</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13448 Title="NL: VolgensAfspraakIndicator">[[Bestand: arrowright.png | 10px | link=]]AsAgreedIndicator</span>
|0..1
|0..1
|Is the medicine used as outlined in the medication agreement?
|Is the medicine used as outlined in the medication agreement?
Regel 162: Regel 178:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px]]
|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
||NL-CM:9.11.22399
||NL-CM:9.11.22399
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruikIndicator">[[Bestand: arrowright.png | 10px]]UseIndicator</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13455 Title="NL: GebruikIndicator">[[Bestand: arrowright.png | 10px | link=]]UseIndicator</span>
|1
|1
|Is this medicine used or not?
|Is this medicine used or not?
Regel 171: Regel 187:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.11.22491
||NL-CM:9.11.22491
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: RedenGebruik">[[Bestand: arrowright.png | 10px]]ReasonForUse</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13449 Title="NL: RedenGebruik">[[Bestand: arrowright.png | 10px | link=]]ReasonForUse</span>
|0..1
|0..1
|The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
|The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
Regel 180: Regel 196:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.11.23132
||NL-CM:9.11.23132
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikStopType">[[Bestand: arrowright.png | 10px]]MedicationUseStopType</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13447 Title="NL: MedicatieGebruikStopType">[[Bestand: arrowright.png | 10px | link=]]MedicationUseStopType</span>
|0..1
|0..1
|Stop type, the manner in which this medication is discontinued (temporary or definitive).
|Stop type, the manner in which this medication is discontinued (temporary or definitive).
Regel 190: Regel 206:
{|
{|
|-
|-
|[[Bestand: List2.png]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
|[[Bestand: List2.png | link=#MedicationUseStopTypeCodeList]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.11.22493
||NL-CM:9.11.22493
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: RedenWijzigenOfStoppenGebruik">[[Bestand: arrowright.png | 10px]]ReasonForChangeOrDiscontinuationOfUse</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13445 Title="NL: RedenWijzigenOfStoppenGebruik">[[Bestand: arrowright.png | 10px | link=]]ReasonForChangeOrDiscontinuationOfUse</span>
|0..*
|0..*
|Reason for changing or discontinuing use of medication.
|Reason for changing or discontinuing use of medication.
Regel 203: Regel 219:
{|
{|
|-
|-
|[[Bestand: List2.png]]||[[#ReasonForChangeOrDiscontinuationOfUseCodList|ReasonForChangeOrDiscontinuationOfUseCodList]]
|[[Bestand: List2.png | link=#ReasonForChangeOrDiscontinuationOfUseCodList]]||[[#ReasonForChangeOrDiscontinuationOfUseCodList|ReasonForChangeOrDiscontinuationOfUseCodList]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.11.21624
||NL-CM:9.11.21624
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Comment</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=13450 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span>
|0..1
|0..1
|Comments on the medication use.
|Comments on the medication use.
Regel 227: Regel 243:
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 18%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruik DatumTijd
| style="background-color: #1F497D; width: 18%; "|<font color=#FFFFFF><b>MedicatieGebruik</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>DatumTijd</b></font>
| style="background-color: #1F497D; width: 4%; color: #FFFFFF; font-weight: bold; "|GebruikIndicator
| style="background-color: #1F497D; width: 4%; "|<font color=#FFFFFF><b>GebruikIndicator</b></font>
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|VolgensAfspraak Indicator
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>VolgensAfspraak</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Indicator</b></font>
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|Medicatiegebruik Stoptype
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>Medicatiegebruik</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Stoptype</b></font>
|colspan="3" style="background-color: #1F497D; width: 27%; color: #FFFFFF; font-weight: bold; "|Gebruiksperiode
|colspan="3" style="background-color: #1F497D; width: 27%; "|<font color=#FFFFFF><b>Gebruiksperiode</b></font>
| style="background-color: #1F497D; width: 28%; color: #FFFFFF; font-weight: bold; "|Gebruiksproduct
| style="background-color: #1F497D; width: 28%; "|<font color=#FFFFFF><b>Gebruiksproduct</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 18%; "|
| style="background-color: #548DD4; width: 18%; "|
Regel 238: Regel 254:
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Ingangsdatum
| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>Ingangsdatum</b></font>
| style="background-color: #548DD4; width: 8%; color: #FFFFFF; font-weight: bold; "|Einddatum
| style="background-color: #548DD4; width: 8%; "|<font color=#FFFFFF><b>Einddatum</b></font>
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Gebruiksduur
| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>Gebruiksduur</b></font>
| style="background-color: #548DD4; width: 28%; color: #FFFFFF; font-weight: bold; "|ProductCode
| style="background-color: #548DD4; width: 28%; "|<font color=#FFFFFF><b>ProductCode</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 18%; "|
| style="background-color: #D9D9D9; width: 18%; "|
Regel 252: Regel 268:
| style="background-color: #D9D9D9; width: 28%; "|
| style="background-color: #D9D9D9; width: 28%; "|
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|3-6-2014 16:19:07
| style="width: 18%; "|3-6-2014 16:19:07
| style="width: 4%; "|Ja
| style="width: 4%; "|Ja
| style="width: 11%; "|
| style="width: 11%; "|
Regel 259: Regel 275:
| style="width: 8%; "|
| style="width: 8%; "|
| style="width: 9%; "|1 maand
| style="width: 9%; "|1 maand
| style="width: 28%; color: #000000; "|Paracetamol tablet 500 mg
| style="width: 28%; "|Paracetamol tablet 500 mg
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|11-9-2012 17:21:00
| style="width: 18%; "|11-9-2012 17:21:00
| style="width: 4%; "|Ja
| style="width: 4%; "|Ja
| style="width: 11%; "|Ja
| style="width: 11%; "|Ja
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 9%; "|01-09-12
| style="width: 9%; "|01-09-12
| style="width: 8%; color: #000000; "|05-09-12
| style="width: 8%; "|05-09-12
| style="width: 9%; "|
| style="width: 9%; "|
| style="width: 28%; color: #000000; "|Pantoprazol injpdr 40 mg fl
| style="width: 28%; "|Pantoprazol injpdr 40 mg fl
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|19-9-2014 4:12:11
| style="width: 18%; "|19-9-2014 4:12:11
| style="width: 4%; "|Nee
| style="width: 4%; "|Nee
| style="width: 11%; "|Nee
| style="width: 11%; "|Nee
| style="width: 11%; "|Definitief
| style="width: 11%; "|Definitief
| style="width: 9%; color: #000000; "|17-09-14
| style="width: 9%; "|17-09-14
| style="width: 8%; "|
| style="width: 8%; "|
| style="width: 9%; "|
| style="width: 9%; "|
| style="width: 28%; color: #000000; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
| style="width: 28%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
|}
|}
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenGebruik
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>RedenGebruik</b></font>
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenWijzigen OfStoppen Gebruik
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>RedenWijzigen</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>OfStoppen</b></font><font color=#FFFFFF><b> </b></font><font color=#FFFFFF><b>Gebruik</b></font>
|colspan="5" style="background-color: #1F497D; width: 59%; color: #FFFFFF; font-weight: bold; "|GebruiksInstructie
|colspan="5" style="background-color: #1F497D; width: 59%; "|<font color=#FFFFFF><b>GebruiksInstructie</b></font>
| style="background-color: #1F497D; width: 19%; "|
| style="background-color: #1F497D; width: 19%; "|
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 16%; color: #FFFFFF; font-weight: bold; "|Omschrijving
| style="background-color: #548DD4; width: 16%; "|<font color=#FFFFFF><b>Omschrijving</b></font>
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
| style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font>
| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Aanvullende instructie
| style="background-color: #548DD4; width: 11%; "|<font color=#FFFFFF><b>Aanvullende instructie</b></font>
| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Doseerinstructie
| style="background-color: #548DD4; width: 11%; "|<font color=#FFFFFF><b>Doseerinstructie</b></font>
| style="background-color: #548DD4; width: 12%; "|
| style="background-color: #548DD4; width: 12%; "|
| style="background-color: #548DD4; width: 19%; "|
| style="background-color: #548DD4; width: 19%; "|
Regel 300: Regel 316:
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; color: Black; font-weight: bold; "|Doseerduur
| style="background-color: #D9D9D9; width: 11%; "|<b>Doseerduur</b>
| style="background-color: #D9D9D9; width: 12%; color: Black; font-weight: bold; "|Dosering<noWiki>|</noWiki> Keerdosis
| style="background-color: #D9D9D9; width: 12%; "|<b>Dosering<noWiki>|</noWiki></b><b> </b><b>Keerdosis</b>
| style="background-color: #D9D9D9; width: 19%; color: #000000; font-weight: bold; "|Toedieningsschema <noWiki>|</noWiki>Frequentie <noWiki>|</noWiki>Interval <noWiki>|</noWiki>Toedientijd <noWiki>|</noWiki>Weekdag <noWiki>|</noWiki>Dagdeel<BR>
| style="background-color: #D9D9D9; width: 19%; "|<b>Toedieningsschema</b><b> </b><b><noWiki>|</noWiki>Frequentie</b><b> </b><b><noWiki>|</noWiki>Interval</b><b> </b><b><noWiki>|</noWiki>Toedientijd</b><b> </b><b><noWiki>|</noWiki>Weekdag</b><b> </b><b><noWiki>|</noWiki>Dagdeel</b><BR>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 11%; "|Pijn
| style="width: 11%; "|Pijn
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 16%; color: #000000; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
| style="width: 16%; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
| style="width: 9%; "|
| style="width: 9%; "|
| style="width: 11%; "|
| style="width: 11%; "|
Regel 315: Regel 331:
| style="width: 11%; "|Ulcusprofylaxe
| style="width: 11%; "|Ulcusprofylaxe
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 16%; color: #000000; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
| style="width: 16%; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
| style="width: 9%; "|iv
| style="width: 9%; "|iv
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; color: #000000; "|40 mg (=1 st)
| style="width: 12%; "|40 mg (=1 st)
| style="width: 19%; "|1x per dag om 8.00 uur
| style="width: 19%; "|1x per dag om 8.00 uur
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 11%; color: #000000; "|(Mogelijke) bijwerking
| style="width: 11%; "|(Mogelijke) bijwerking
| style="width: 16%; color: #000000; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
| style="width: 16%; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
| style="width: 9%; "|subcutaan
| style="width: 9%; "|subcutaan
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; color: #000000; "|2500 IE
| style="width: 12%; "|2500 IE
| style="width: 19%; color: #000000; "|1x per dag om 18.00 uur<BR>
| style="width: 19%; "|1x per dag om 18.00 uur<BR>
|}
|}


Regel 468: Regel 484:




==This information model in other releases==
---
==More on this information model==
==More on this information model==
More technical information and HL7/XML documentation you can find on the Nictiz Art-Decor page about this information model[http://decor.nictiz.nl/art-decor/decor-datasets--zib1bbr-?id=2.16.840.1.113883.2.4.3.11.60.40.3.9.11] <BR>
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.11&effectiveDate=2017-09-04T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=StructureDefinition [[File:fhir.png|link=]]]</li>
</ul>
This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
==About this information==
The information in this wikipage is based on Prerelease 2017 #1 <BR>
The information in this wikipage is based on Prerelease 2017 #1 <BR>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
This page is generated on 28/09/2017 10:58:15 <BR>
This page is generated on 30/11/2017 13:37:32 <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>

Versie van 30 nov 2017 13:42

General information

Name: nl.zorg.MedicationUse2 NL.png
Version: 1.0
HCIM Status:Final
Release: 2017
Release status: Prepublished
Release date: 04-09-2017

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom
DCM::ContentAuthorList Projectgroep Medicatieproces
DCM::CreationDate 1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.9.11
DCM::KeywordList Medicatie, Gebruik
DCM::LifecycleStatus Final
DCM::ModelerList Architectuurgroep Registratie aan de Bron
DCM::Name nl.zorg.MedicatieGebruik2
DCM::PublicationDate 04-09-2017
DCM::PublicationStatus Prepublished
DCM::ReviewerList Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate 04-09-2017
DCM::Superseeds nl.zorg.MedicatieGebruik-v3.0
DCM::Version 1.0
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017).

Concept

MedicationUse is a statement on the historic, current or intended use of a certain medicine.

Purpose

The goal of the medication use is to provide insight into the patient’s pattern of use.

Information Model


HealthProfessional-v3.1(2017EN)#ReasonForChangeOrDiscontinuationOfUseCodList#MedicationUseStopTypeCodeList#13447#13449InstructionsForUse-v1.0(2017EN)#13450Product-v1.0(2017EN)#13455#13448#13445TimeInterval-v1.0(2017EN)#13451#13453MedicationUse2-v1.0Model(EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:9.11.21338 Arrowdown.pngMedicationUse Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
Verwijzing.png NL-CM:9.11.23290 Arrowright.pngPrescriber::HealthProfessional 0..1 The health professional that entered the medication agreement with the patient.
Block.png HealthProfessional
Verwijzing.png NL-CM:9.11.21339 Arrowright.pngProductUsed::Product 1 The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.

In principle, this will be the prescribed product, but the product used may differ from the prescribed product.

Block.png Product
Verwijzing.png NL-CM:9.11.22504 Arrowright.pngInstructionsForUse 0..1 Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.
Block.png InstructionsForUse
TS.png NL-CM:9.11.22398 Arrowright.pngMedicationUseDateTime 1 Date on which this use is entered.
Verwijzing.png NL-CM:9.11.22663 Arrowright.pngPeriodOfUse 0..1 Start date: This is the time at which the agreement was to take effect (or took effect or will take effect).

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days. End date: The time at which the period of use ends (or ended or will end). To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

Block.png TimeInterval
BL.png NL-CM:9.11.22492 Arrowright.pngAsAgreedIndicator 0..1 Is the medicine used as outlined in the medication agreement?
BL.png NL-CM:9.11.22399 Arrowright.pngUseIndicator 1 Is this medicine used or not?
ST.png NL-CM:9.11.22491 Arrowright.pngReasonForUse 0..1 The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
CD.png NL-CM:9.11.23132 Arrowright.pngMedicationUseStopType 0..1 Stop type, the manner in which this medication is discontinued (temporary or definitive).
List2.png MedicationUseStopTypeCodeList
CD.png NL-CM:9.11.22493 Arrowright.pngReasonForChangeOrDiscontinuationOfUse 0..* Reason for changing or discontinuing use of medication.
List2.png ReasonForChangeOrDiscontinuationOfUseCodList
ST.png NL-CM:9.11.21624 Arrowright.pngComment 0..1 Comments on the medication use.
48767-8 Annotation comment

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

MedicatieGebruik DatumTijd GebruikIndicator VolgensAfspraak Indicator Medicatiegebruik Stoptype Gebruiksperiode Gebruiksproduct
Ingangsdatum Einddatum Gebruiksduur ProductCode
3-6-2014 16:19:07 Ja Mei 2014 1 maand Paracetamol tablet 500 mg
11-9-2012 17:21:00 Ja Ja 01-09-12 05-09-12 Pantoprazol injpdr 40 mg fl
19-9-2014 4:12:11 Nee Nee Definitief 17-09-14 Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
RedenGebruik RedenWijzigen OfStoppen Gebruik GebruiksInstructie
Omschrijving ToedieningsWeg Aanvullende instructie Doseerinstructie
Doseerduur Dosering| Keerdosis Toedieningsschema |Frequentie |Interval |Toedientijd |Weekdag |Dagdeel
Pijn In de maand mei heb ik regelmatig paracetamol gebruikt.
Ulcusprofylaxe Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st) iv 40 mg (=1 st) 1x per dag om 8.00 uur
(Mogelijke) bijwerking Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid. subcutaan 2500 IE 1x per dag om 18.00 uur

Valuesets

MedicationUseStopTypeCodeList

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1
Conceptname Conceptcode Codesystem name Codesystem OID Description
Tijdelijk 1 Medicatieafspraak StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief 2 Medicatie afspraak StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Het staken van een bestaande medicamenteuze behandeling.

ReasonForChangeOrDiscontinuationOfUseCodList

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2
Conceptname Conceptcode Codesystem name Codesystem OID Description
Medication commenced (finding) 266709005 SNOMED CT 2.16.840.1.113883.6.96 Starten medicamenteuze behandeling
Administration of drug or medicament contraindicated (situation) 438833006 SNOMED CT 2.16.840.1.113883.6.96 Contra-indicatie
Drug interaction (disorder) 79899007 SNOMED CT 2.16.840.1.113883.6.96 Interactie
Hypersensitivity condition (disorder) 473010000 SNOMED CT 2.16.840.1.113883.6.96 Overgevoeligheid
Geen of onvoldoende effect 5 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Geen of onvoldoende effect
Te sterk effect 6 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Te sterk effect
(Mogelijke) bijwerking 7 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 (Mogelijke) bijwerking
Toedieningsweg voldoet niet 8 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Toedieningsweg voldoet niet
Indicatie vervallen 9 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Indicatie vervallen
Beleidswijziging 10 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Beleidswijziging
Admission to establishment (procedure) 305335007 SNOMED CT 2.16.840.1.113883.6.96 Opname
Wens patiënt 12 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Wens patiënt
Volgens afspraak 13 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Volgens afspraak
Hervatten beleid vorige voorschrijver 14 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Hervatten beleid vorige voorschrijver
Geplande procedure 15 Medicatieafspraak Reden 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
Overig OTH NullFlavour 2.16.840.1.113883.5.1008 Overig


This information model in other releases

---

More on this information model

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Prerelease 2017 #1
Conditions for use are located on the mainpage List2.png
This page is generated on 30/11/2017 13:37:32

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=MedicationUse2-v1.0(2017EN)&oldid=8296"